Print…

You Searched For: 4-Bromo-L-phenylalanine


86,318  results were found

Refine Results Sort by

Sort Results

List View Easy View
SearchResultCount:"86318"

Rate These Search Results

Image Unavailable-10325-096

Anti-ADAR Rabbit Polyclonal Antibody (FITC (Fluorescein Isothiocyanate))

Description: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence.
Catalog Number: 10325-096
Supplier: Bioss
Image Unavailable-10325-090

Anti-ADAR Rabbit Polyclonal Antibody (Cy5®)

Description: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence.
Catalog Number: 10325-090
Supplier: Bioss
Image Unavailable-10325-092

Anti-ADAR Rabbit Polyclonal Antibody (Cy5.5®)

Description: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence.
Catalog Number: 10325-092
Supplier: Bioss
Image Unavailable-76110-850

Anti-GPR71 Rabbit Polyclonal Antibody (Alexa Fluor® 680)

Description: The sense of taste provides animals with valuable information about the quality and nutritional value of food. There are four widely accepted categories of taste perception, sweet, bitter, salty, and sour. A controversial fifth taste, known as umami or monosodium glutamate (MSG), has also been described. A family of G protein coupled receptors are involved in taste perception, and includes T1R, which is involved in sweet and umami taste perception, and T2R, which is involved in bitter taste perception. The T1R family consists of three members, T1R1, T1R2, and T1R3. These proteins form heterodimers, which alters the selectivity of the subunits. The T1R2 and T1R3 heterodimer functions as a receptor for sweet taste, and recognizes several sweet-tasting molecules, such as sucrose, saccharin, dulcin, and acesulfame-K. The T1R1 and T1R3 heterodimer recognizes L-amino-acids to perceive umami taste. Sweet taste transduction is carried out by two pathways. First, sucrose and other sugars activate Gas via the T1Rs, which activates adenylyl cyclase to generate cAMP. Artificial sweeteners bind to either Gbg or Gaq coupled T1Rs to activate PLCb2 and generate IP3 and DAG. Both pathways ultimately lead to neurotransmitter release. The mouse T1R3 gene maps to chromosome 4 near the Sac locus, a primary determinant of sweet preference in mice, and it is expressed in a subset of taste cells in circumvallate, foliate, and fungiform taste papillae.
Catalog Number: 76110-850
Supplier: Bioss
Product Image-76733-126

Human Glutamate Dehydrogenase ELISA Kit

Description: Human Glutamate Dehydrogenase ELISA kit is a sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the <i>in vitro</i> quantitative determination of human Glutamate Dehydrogenase in serum, plasma, tissue homogenates, and other biological fluids.
Catalog Number: 76733-126
Supplier: ANTIBODIES.COM LLC
Image Unavailable-TCB0815-025G

p-Benzanisidide ≥98.0% (by GC, total nitrogen)

Description: CAS Number: 7472-54-0
MDL Number: MFCD00025788
Molecular Formula: C14H13NO2
Molecular Weight: 227.26
Purity/Analysis Method: >98.0% (GC,N)
Form: Crystal
Melting point (°C): 155
Catalog Number: TCB0815-025G
Supplier: TCI America

SDS


Image Unavailable-76121-040

Anti-PGCP Rabbit Polyclonal Antibody (Alexa Fluor® 750)

Description: PGCP is a 472 amino acid secreted protein that is primarily detected in blood plasma. PGCP is a carboxypeptidase that potentially is involved in the hydrolysis of circulating peptides. Due to its upregulation in hepatocellular carcinoma (HCC), it is suspected that PGCP may be a potential serological marker for HCC. PGCP is a member of the Peptidase M28 family of proteins, which also includes PSM (prostate-specific membrane antigen), metallopeptidases and aminopeptidases. The gene encoding PGCP maps to chromosome 8, which is made up of nearly 146 million bases and encodes about 800 genes. Translocation of portions of chromosome 8 with amplifications of the c-Myc gene are found in some leukemias and lymphomas, and are typically associated with a poor prognosis. In humans, PGCP is found principally in blood plasma. It is a Carboxypeptidase that may play an important role in the hydrolysis of circulating peptides.
Catalog Number: 76121-040
Supplier: Bioss
Product Image-76703-444

Human Glutamate (Glu) ELISA Kit

Description: Human Glutamate (Glu) ELISA Kit
Catalog Number: 76703-444
Supplier: AFG Bioscience
Image Unavailable-ABCA_AB9440-500UL

Anti-L Glutamate Rabbit Polyclonal Antibody

Description: Rabbit polyclonal to L Glutamate.
Catalog Number: ABCA_AB9440-500UL
Supplier: Abcam

New Product


Product Image-76711-750

Mouse Glutamate Decarboxylase 1(GAD1) ELISA Kit

Description: Mouse Glutamate Decarboxylase 1(GAD1) ELISA Kit
Catalog Number: 76711-750
Supplier: AFG Bioscience
Product Image-76716-152

Mouse Glutamate(Glu) ELISA Kit

Description: Mouse Glutamate(Glu) ELISA Kit
Catalog Number: 76716-152
Supplier: AFG Bioscience
Product Image-10068-446

Anti-GRIA2 Rabbit Polyclonal Antibody

Description: Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist.
Catalog Number: 10068-446
Supplier: Prosci
Product Image-76711-754

Mouse Glutamate Dehydrogenase(GDH/GLDH) ELISA Kit

Description: Mouse Glutamate Dehydrogenase(GDH/GLDH) ELISA Kit
Catalog Number: 76711-754
Supplier: AFG Bioscience
Image Unavailable-89296-094

Anti-GLUD1 Goat Polyclonal Antibody

Description: Goat polyclonal antibody to Glutamate Dehydrogenase
Catalog Number: 89296-094
Supplier: Genetex
Product Image-76702-290

Rat Glutamate(Glu) ELISA Kit

Description: Rat Glutamate(Glu) ELISA Kit
Catalog Number: 76702-290
Supplier: AFG Bioscience
Product Image-89161-708

Sivelestat sodium ≥98% (by HPLC)

Description: Potent and selective leukocyte elastase inhibitor (IC50=44nM). Displays various anti-inflammatory activities including attenuation of LTB4-induced neutrophil migration and serum cytokine levels. Reduces acute inflammatory lung injury in vivo.
Catalog Number: 89161-708
Supplier: Enzo Life Sciences
433 - 448 of 86,318